Investors Must Be Tripping...

There's been a lot of hype around this stock lately... [Shield] AN OXFORD CLUB PUBLICATION [Wealthy Retirement]( [View in browser]( SPONSORED [Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move]( [Nate Beat - Play button]( He started from nothing and became a multimillionaire... He's now one of the most sought-after trading experts... Yet he operates 858 miles from Wall Street. And now, he's revealing his No. 1 favorite strategy that targets MASSIVE weekly profits with just one stock ticker. [SEE THE PROOF HERE]( [THE VALUE METER]( [Are MindMed Investors Tripping?]( [Anthony Summers, Director of Trading, The Oxford Club]( [Anthony Summers]( Mind Medicine (Nasdaq: MNMD) has been riding high on the psychedelic medicine wave. Often called MindMed, the company is developing novel therapies derived from psychedelic compounds to treat brain health disorders, with a focus on anxiety and addiction. Like cannabis-based medicine before it, psychedelic medicine has garnered quite a bit of attention, and the hype has pumped up MindMed's stock. As you can see in the chart, shares skyrocketed from their late 2023 lows of around $2.50 to a peak above $11.50 earlier this year - an incredibly fast 360% gain in under six months. [Chart: Mind Medicine (Nasdaq: MNMD)]( [View larger image]( The stock has since retreated to about $7.50, but it's still up significantly from its lows. The question is... has the stock's valuation gotten a bit too trippy? Let's run this biotech through The Value Meter to find out. MindMed's enterprise value-to-net asset value (EV/NAV) ratio of 5.78 is well below the average of 10.95 for companies with positive net assets. Not bad at first glance. The real red flag is MindMed's cash burn. The company has recorded negative free cash flow in each of the past four quarters. On average, it's burning through the equivalent of 15.32% of its net assets each quarter. While that's better than the 24.19% average for firms with similarly poor cash flow, it's still concerning. MindMed's latest financial results also paint a clear picture... [See What I Mean Here]( [Investment U Conference 2025 - Ponte Vedra Inn & Club in Ponte Vedra Beach, Florida, March 30-April 2, 2025]( SPONSORED [This FREE Package Reveals AI Stocks That Pay You CASH]( It's 100% free. Take it and [learn how to get paid to invest in AI dividends](. BUILD AND PROTECT YOUR WEALTH [Discover the Top Passive Income Opportunity for 2024...]( [Next Era of Human Progress Unleashed]( [Famous Trader Puts AI To The Test (You're Not Going To Believe This)]( [Your Personalized Path to Financial Freedom]( MORE FROM WEALTHY RETIREMENT [Article]( [Did Verizon Earn an Upgrade?]( [Article]( [Is the Stock Market in a Correction?]( [Article]( [How Much Should Retirees Invest in Stocks?]( [Article]( [Beat the Market by Following Biotech Insiders]( [Facebook]( [Facebook]( [LinkedIn logo]( [LinkedIn]( [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AThis pharmaceutical company has been surging... Are investors tripping?!%0D%0A%0D [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AThis pharmaceutical company has been surging... Are investors tripping?!%0D%0A%0D [Push Alert]( [Push Alert]( SPONSORED [Alex Green's #1 AI Investment]( [Alex on set]( He believes in one tiny AI company so much that he's put in over $100,000 of his own money... But YOU can get in for as little as $5. [Click Here to Get All the Details]( [The Oxford Club]( You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Wealthy Retirement]( | [Unsubscribe]( © 2024 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [877.808.9795](#) | International: [+1.443.353.4621](#) [Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.